WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 71.00
+1.70 (2.45%)
Mar 5, 2026, 12:33 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.23 billion as of March 5, 2026. Its market cap has decreased by -3.29% in one year.
Market Cap
3.23B
Enterprise Value
3.79B
Revenue
1.06B
Ranking
n/a
PE Ratio
16.40
Stock Price
71.00
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.23B, a decrease of -5.87%. That is a compound annual growth rate of -2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.23B | -3.27% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.63B |
| InnoCare Optoelectronics | 5.19B |
| Bonraybio | 4.22B |
| Medimaging Integrated Solution | 3.18B |
| A Plus Biotechnology | 2.84B |
| Applied BioCode | 2.62B |
| Dynamic Medical Technologies | 2.34B |
| Wellell | 2.32B |